Guided duration of anticoagulation after unprovoked venous thromboembolism using D-dimer testing Source: Eur Respir J 2016; 47:1313-1314 Year: 2016
Does D-dimer levels on admission predicts venous thromboembolism in patients with COVID-19? Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors Year: 2021
D-dimer testing and pre-test probability scoring in the diagnosis of venous thromboembolism Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism Year: 2011
D-dimer in patients with venous thromboembolism who carry hereditary thrombophilia Source: Eur Respir J 2006; 28: Suppl. 50, 46s Year: 2006
Incidental venous thromboembolism, detected by chance, but still venous thromboembolism Source: Eur Respir J, 55 (2) 2000028; 10.1183/13993003.00028-2020 Year: 2020
Age is a major risk factor of venous thromboembolism (VTE) Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism Year: 2011
Compliance with venous thromboembolic (VTE) risk assessment and prophylaxis in medical inpatients at an English DGH Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease Year: 2010
The acquired and inherited risk factors in venous thromboembolism (VTE) Source: Eur Respir J 2003; 22: Suppl. 45, 220s Year: 2003
A single centre experience of low dose direct oral anticoagulants (DOAC) after unprovoked venous thromboembolism (VTE) Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism Year: 2019
Venous thromboembolism (VTE) prophylaxis in acute medical admissions to a university hospital Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases Year: 2009
Venous thromboembolic (VTE) in patients with ALS: an incidence study Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes Year: 2021
The prevalence of hyperhomocysteinemia in venous thromboembolism Source: Eur Respir J 2006; 28: Suppl. 50, 48s Year: 2006
The changing of D-dimer in the thrombolytic process of pulmonary thromboembolism Source: Eur Respir J 2006; 28: Suppl. 50, 401s Year: 2006
Evaluation of the medical knowledge degree about clinical suspicion of pulmonary thromboembolism (PTE) Source: Eur Respir J 2006; 28: Suppl. 50, 46s Year: 2006
Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment Source: Eur Respir J 2016; 48: 1369-1376 Year: 2016
Predicting anticoagulant-related bleeding in patients with venous thromboembolism: a clinically oriented review Source: Eur Respir J 2015; 45: 201-210 Year: 2015
Factors that predict the risk of recurrent venous thromboembolism (VTE) in patients with VTE and factor V Leiden (FVL) Source: Annual Congress 2010 - Pulmonary embolism Year: 2010
Risk factors in patients with venous thromboembolism Source: Eur Respir J 2002; 20: Suppl. 38, 239s Year: 2002
Evaluation of the PADIS score stratifying risk for venous thromboembolism recurrence after a first unprovoked pulmonary embolism: results from the REVERSE study Source: Eur Respir J, 59 (2) 2101801; 10.1183/13993003.01801-2021 Year: 2022
Risks of pulmonary thromboembolism associated with ambulatory management of clinically proven deep vein thrombosis Source: Annual Congress 2005 - News about pulmonary embolism Year: 2005